Chronic Obstructive Pulmonary Disease and Hepatitis C

Chronic obstructive pulmonary disease (COPD) is a preventable, treatable disease with significant extrapulmonary manifestations that could affect negatively its course in some patients. Hepatitis C virus infection (HCV), on the other hand, is associated with a number of extrahepatic manifestations....

Full description

Bibliographic Details
Main Authors: Mekov Evgeni V., Petkov Rosen E., Kostadinov Dimitar T., Antonov Krasimir A., Jelev Deian T.
Format: Article
Language:English
Published: Pensoft Publishers 2017-06-01
Series:Folia Medica
Subjects:
HCV
Online Access:http://www.degruyter.com/view/j/folmed.2017.59.issue-2/folmed-2017-0018/folmed-2017-0018.xml?format=INT
id doaj-0f346382a2304815aa116d461cdf62df
record_format Article
spelling doaj-0f346382a2304815aa116d461cdf62df2020-11-24T21:19:27ZengPensoft PublishersFolia Medica 1314-21432017-06-0159213213810.1515/folmed-2017-0018folmed-2017-0018Chronic Obstructive Pulmonary Disease and Hepatitis CMekov Evgeni V.0Petkov Rosen E.1Kostadinov Dimitar T.2Antonov Krasimir A.3Jelev Deian T.4Clinical Center for Pulmonary Diseases, St. Sofia Hospital for Pulmonary Diseases, Medical University of Sofia, Sofia, BulgariaClinical Center for Pulmonary Diseases, St. Sofia Hospital for Pulmonary Diseases, Medical University of Sofia, Sofia, BulgariaClinical Center for Pulmonary Diseases, St. Sofia Hospital for Pulmonary Diseases, Medical University of Sofia, Sofia, BulgariaClinic of Gastroenterology, St. Ivan Rilski University Hospital, Medical University of Sofia, Sofia, BulgariaClinic of Gastroenterology, St. Ivan Rilski University Hospital, Medical University of Sofia, Sofia, BulgariaChronic obstructive pulmonary disease (COPD) is a preventable, treatable disease with significant extrapulmonary manifestations that could affect negatively its course in some patients. Hepatitis C virus infection (HCV), on the other hand, is associated with a number of extrahepatic manifestations. COPD patients have increased prevalence of HCV and patients with HCV, especially older ones, have increased prevalence and faster progression of COPD. HCV infection exerts long-term effects on lung tissue and is an additional risk factor for the development of COPD. The presence of HCV is associated with an accelerated loss of lung function in COPD patients, especially in current smokers. COPD could represent extrahepatic manifestation associated with HCV infection. The aim of this article was to review the literature on prevalence of HCV in COPD and vice versa, pathogenetic link and the consequences of their mutual existence.http://www.degruyter.com/view/j/folmed.2017.59.issue-2/folmed-2017-0018/folmed-2017-0018.xml?format=INTCOPDhepatitis CHCVcomorbidity
collection DOAJ
language English
format Article
sources DOAJ
author Mekov Evgeni V.
Petkov Rosen E.
Kostadinov Dimitar T.
Antonov Krasimir A.
Jelev Deian T.
spellingShingle Mekov Evgeni V.
Petkov Rosen E.
Kostadinov Dimitar T.
Antonov Krasimir A.
Jelev Deian T.
Chronic Obstructive Pulmonary Disease and Hepatitis C
Folia Medica
COPD
hepatitis C
HCV
comorbidity
author_facet Mekov Evgeni V.
Petkov Rosen E.
Kostadinov Dimitar T.
Antonov Krasimir A.
Jelev Deian T.
author_sort Mekov Evgeni V.
title Chronic Obstructive Pulmonary Disease and Hepatitis C
title_short Chronic Obstructive Pulmonary Disease and Hepatitis C
title_full Chronic Obstructive Pulmonary Disease and Hepatitis C
title_fullStr Chronic Obstructive Pulmonary Disease and Hepatitis C
title_full_unstemmed Chronic Obstructive Pulmonary Disease and Hepatitis C
title_sort chronic obstructive pulmonary disease and hepatitis c
publisher Pensoft Publishers
series Folia Medica
issn 1314-2143
publishDate 2017-06-01
description Chronic obstructive pulmonary disease (COPD) is a preventable, treatable disease with significant extrapulmonary manifestations that could affect negatively its course in some patients. Hepatitis C virus infection (HCV), on the other hand, is associated with a number of extrahepatic manifestations. COPD patients have increased prevalence of HCV and patients with HCV, especially older ones, have increased prevalence and faster progression of COPD. HCV infection exerts long-term effects on lung tissue and is an additional risk factor for the development of COPD. The presence of HCV is associated with an accelerated loss of lung function in COPD patients, especially in current smokers. COPD could represent extrahepatic manifestation associated with HCV infection. The aim of this article was to review the literature on prevalence of HCV in COPD and vice versa, pathogenetic link and the consequences of their mutual existence.
topic COPD
hepatitis C
HCV
comorbidity
url http://www.degruyter.com/view/j/folmed.2017.59.issue-2/folmed-2017-0018/folmed-2017-0018.xml?format=INT
work_keys_str_mv AT mekovevgeniv chronicobstructivepulmonarydiseaseandhepatitisc
AT petkovrosene chronicobstructivepulmonarydiseaseandhepatitisc
AT kostadinovdimitart chronicobstructivepulmonarydiseaseandhepatitisc
AT antonovkrasimira chronicobstructivepulmonarydiseaseandhepatitisc
AT jelevdeiant chronicobstructivepulmonarydiseaseandhepatitisc
_version_ 1726005206291841024